NCT07047989View on ClinicalTrials.gov

NWRD09 for HPV-16 Related Cervical HSIL

PHASE1RecruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

June 12, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions
High-grade Squamous Intraepithelial Lesion (HSIL)
Interventions
BIOLOGICAL

NWRD09 injection

NWRD09 administered by intramuscular injection

Trial Locations (1)

Unknown

RECRUITING

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Newish Biotech (Wuxi) Co., Ltd.

INDUSTRY